PAM variants in patients with thyrotrophinomas, cyclical Cushing’s disease and prolactinomas

Overview of attention for article published in Frontiers in endocrinology, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,295 followers.

RT @FrontEndocrinol: New Research: PAM variants in patients with thyrotrophinomas, cyclical Cushing’s disease and prolactinomas: Introducti…

24 Nov 2023

Reply Repost Favourite

New Research: PAM variants in patients with thyrotrophinomas, cyclical Cushing’s disease and prolactinomas: Introduction Germline loss-of-function variants in PAM, encoding peptidylglycine α-amidating monooxygenase (PAM), were… https://t.co/FGUV1TW7LO #En

23 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.